News Headlines Article

Prices for many generic drugs rising faster than inflation
Modern Healthcare

Prices rose faster than inflation for 22% of top generic drugs reviewed between 2005 and 2014, according to a report released Thursday by HHS‘ Office of Inspector General. Had those generic drugs been subject to the same requirement that branded drugs face — where manufacturers pay additional rebates to Medicaid when the price of a drug increases faster than inflation — Medicaid would have pulled in $1.4 billion in rebates for the top 200 generic drugs, according to the report.